Premature ovarian failure--the prognostic application of autoimmunity on conception after ovulation induction.
OBJECTIVE
To assess whether the presence of autoimmune activity in patients with premature ovarian failure (POF) can predict the response to ovulation induction and conception.


METHODS
Assessment of autoimmune activity in patients with POF, correlating the response to ovulation induction with this autoreactivity.


METHODS
Tertiary care academic center.


METHODS
Forty women with POF, 15 of them treated by ovulation induction because of infertility.


METHODS
All patients were tested for the presence of autoimmune activity, antibodies against various tissues, and 15 of them were treated with combinations of hMG/hCG, glucocorticosteroids as immunosuppressant, and some of them also with a long-acting GnRH agonist. Those patients not interested in infertility were put on hormone replacement therapy (HRT).


METHODS
Serum E2 and P were measured during ovulation induction as well as follicular diameter monitoring by transvaginal sonography. Achievement of gestations and their outcome were monitored in the group in which ovulation induction was accomplished.


RESULTS
Antibodies against thyroglobulin, nuclear antigens, heart, tissue gluten, or increased levels of immunoglobulin (Ig)M, or decreased levels of complement C3 and C4 were significantly different in the patients with POF than in the control population. Autoreactivity of at least one class of the tested antibodies was found in 31 of 40 patients (77%). In 15 patients with autoimmune activity who have undergone ovulation induction using hMG/hCG, 14 pregnancies were achieved in 8 patients. Two of the pregnancies were spontaneous, and 12 were generated by hMG/hCG and fluocortolone, with or without pretreatment with GnRH-a. Twelve healthy babies were generated by 10 gestations, 3 ended in spontaneous abortions (23%), and 1 is ongoing. All the nonspontaneous pregnancies were achieved in the first three cycles of ovulation induction.


CONCLUSIONS
Patients with POF and autoimmune activity, suggesting an autoimmune etiology to the ovarian failure, may respond to ovulation induction and have a conception rate of approximately 40% in three cycles. Those who do not conceive in three treatment cycles have a very low probability to conceive; therefore, further attempts of ovulation induction should be discouraged. However, some patients may spontaneously conceive in association with HRT.
Blumenfeld
Z
Z
Rambam Medical Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa.
Halachmi
S
S
Peretz
B A
BA
Shmuel
Z
Z
Golan
D
D
Makler
A
A
Brandes
J M
JM
D000328:Adult; D001327:Autoimmune Diseases / Q000503:physiopathology*; D015914:Estrogen Replacement Therapy; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006801:Humans; D010062:Ovulation Induction; D011247:Pregnancy; D016649:Primary Ovarian Insufficiency / Q000276:immunology / Q000503:physiopathology*; D011379:Prognosis; D011962:Receptors, FSH / Q000502:physiology
D012739:Gonadal Steroid Hormones; D011962:Receptors, FSH